Upstate Active Clinical Trials

Study Title:

EAY191-Molecular Analysis for Combination Therapy Choice (ComboMATCH)

What is the purpose of the study? (in Layman's terms, please describe the study)

Registration trial aimed to establish whether patients with tumor mutations in one of the genetic pathways of interest are likely to derive clinical benefit if treated with combinations of agents targeting that specific pathway.

Upstate Institutional Review Board (IRB) Number:

2093307

Study/Protocol ID:

EAY191

Study Phase:

2

Patient Age Group:

Adults

Principal Investigator:

Mary J Cunningham, MD

What is involved if I participate?

• How long is the study?
  enrollment should occur within 6 months if eligible for combomatch studies after registration.
• Is transportation provided or reimbursed?
  No
• Is parking provided or reimbursed?
  No
• What tests and procedures are involved?
  Tumor biopsy/archival tissue

Where will the study take place?

Cancer Center or Madison Irving GYN oncology

Other Information:

N/A

ClinicalTrials.Gov ID:

NCT05564377

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Sarah Clark, BS
Phone: 315-464-8276
Email: [email protected]

Return to Previous Page || Search Again